Skip to content
Home/Companies/Biotech/Novonesis

Novonesis

Biotech·Denmark·Active·26yr hold
Entry
2000
Hold
26yr
Status
Active

Who owns Novonesis?

Novonesis is a Danish Biotech company, currently owned by Novo Holdings since 2000.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Novo Holdings
Investor
Novo Holdings
Novo Holdings Principal Investments · 1999 · Buyout

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Novo Holdings Principal Investments

Other portfolio companies in the same fund.

Tempus AI
Active
HealthTechUS· 2026
Benchmark Genetics
Active
AgTechUK· 2025
KalVista Pharmaceuticals
Active
PharmaUS· 2025
Schott Poonawalla
Active
IndustrialsIndia· 2025
Catalent
Active
PharmaUS· 2024
Inozyme Pharma
Exited 2025
BiotechUS· 2023
to BioMarin Pharmaceutical

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Novonesis?

Novonesis is currently owned by Novo Holdings, through Novo Holdings Principal Investments, since 2000.

When did Novo Holdings acquire Novonesis?

Novo Holdings acquired Novonesis in 2000.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue